Lack of Additive Effects of Resveratrol and Energy Restriction in the Treatment of Hepatic Steatosis in Rats

Nutrients. 2017 Jul 11;9(7):737. doi: 10.3390/nu9070737.

Abstract

The aims of the present study were to analyze the effect of resveratrol on liver steatosis in obese rats, to compare the effects induced by resveratrol and energy restriction and to research potential additive effects. Rats were initially fed a high-fat high-sucrose diet for six weeks and then allocated in four experimental groups fed a standard diet: a control group, a resveratrol-treated group, an energy restricted group and a group submitted to energy restriction and treated with resveratrol. We measured liver triacylglycerols, transaminases, FAS, MTP, CPT1a, CS, COX, SDH and ATP synthase activities, FATP2/FATP5, DGAT2, PPARα, SIRT1, UCP2 protein expressions, ACC and AMPK phosphorylation and PGC1α deacetylation. Resveratrol reduced triacylglycerols compared with the controls, although this reduction was lower than that induced by energy restriction. The mechanisms of action were different. Both decreased protein expression of fatty acid transporters, thus suggesting reduced fatty acid uptake from blood stream and liver triacylglycerol delivery, but only energy restriction reduced the assembly. These results show that resveratrol is useful for liver steatosis treatment within a balanced diet, although its effectiveness is lower than that of energy restriction. However, resveratrol is unable to increase the reduction in triacylglycerol content induced by energy restriction.

Keywords: energy restriction; liver steatosis; rat; resveratrol.

MeSH terms

  • AMP-Activated Protein Kinases / genetics
  • AMP-Activated Protein Kinases / metabolism
  • Acetyl-CoA Carboxylase / genetics
  • Acetyl-CoA Carboxylase / metabolism
  • Alanine Transaminase / blood
  • Animals
  • Aspartate Aminotransferases / blood
  • Caloric Restriction*
  • Coenzyme A Ligases / genetics
  • Coenzyme A Ligases / metabolism
  • Diacylglycerol O-Acyltransferase / genetics
  • Diacylglycerol O-Acyltransferase / metabolism
  • Diet, High-Fat / adverse effects
  • Fatty Acid Transport Proteins / genetics
  • Fatty Acid Transport Proteins / metabolism
  • Fatty Acids / administration & dosage
  • Fatty Liver / drug therapy*
  • Liver / drug effects
  • Liver / metabolism
  • Male
  • Organ Size / drug effects
  • PPAR alpha / genetics
  • PPAR alpha / metabolism
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha / genetics
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha / metabolism
  • Rats
  • Rats, Wistar
  • Resveratrol
  • Sirtuin 1 / genetics
  • Sirtuin 1 / metabolism
  • Stilbenes / pharmacology*
  • Triglycerides / blood
  • Uncoupling Protein 2 / genetics
  • Uncoupling Protein 2 / metabolism

Substances

  • Fatty Acid Transport Proteins
  • Fatty Acids
  • PPAR alpha
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • Ppargc1a protein, rat
  • Stilbenes
  • Triglycerides
  • Ucp2 protein, rat
  • Uncoupling Protein 2
  • Dgat2 protein, rat
  • Diacylglycerol O-Acyltransferase
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • AMP-Activated Protein Kinases
  • Sirt1 protein, rat
  • Sirtuin 1
  • Coenzyme A Ligases
  • Slc27a2 protein, rat
  • Acetyl-CoA Carboxylase
  • Resveratrol